Literature DB >> 21639936

Systemic epidermal nevus with involvement of the oral mucosa due to FGFR3 mutation.

Anette Bygum1, Christina R Fagerberg, Ole J Clemmensen, Britta Fiebig, Christian Hafner.   

Abstract

BACKGROUND: Epidermal nevi (EN) represent benign congenital skin lesions following the lines of Blaschko. They result from genetic mosaicism, and activating FGFR3 and PIK3CA mutations have been implicated. CASE
PRESENTATION: We report a female patient with a systemic keratinocytic nevus also involving the oral mucosa. Molecular genetic analysis revealed a mosaicism of the FGFR3 hotspot mutation R248C in the EN lesions of the skin and of the oral mucosa. The detection of the R248C mutation in a proportion of blood leukocytes and a slight scoliosis suggest an EN syndrome.
CONCLUSIONS: Our results show that activating FGFR3 mutations can also affect the oral mucosa and that extracutaneous manifestations of EN syndrome can be subtle. We highlight the theoretical risk of the patient having an offspring with thanatophoric dysplasia as gonadal mosaicism for the R248C mutation cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639936      PMCID: PMC3119182          DOI: 10.1186/1471-2350-12-79

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


  31 in total

Review 1.  Epidermal nevi.

Authors:  Rudolf Happle; Maureen Rogers
Journal:  Adv Dermatol       Date:  2002

2.  Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors.

Authors:  Christian Hafner; Agustí Toll; Alejandro Fernández-Casado; Julie Earl; Miriam Marqués; Francesco Acquadro; Marinela Méndez-Pertuz; Miguel Urioste; Núria Malats; Julie E Burns; Margaret A Knowles; Juan C Cigudosa; Arndt Hartmann; Thomas Vogt; Michael Landthaler; Ramón M Pujol; Francisco X Real
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-15       Impact factor: 11.205

3.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Authors:  M Chesi; E Nardini; L A Brents; E Schröck; T Ried; W M Kuehl; P L Bergsagel
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  Cancer-specific mutations in PIK3CA are oncogenic in vivo.

Authors:  Andreas G Bader; Sohye Kang; Peter K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors.

Authors:  Silvia Hernández; Agustí Toll; Eulàlia Baselga; Adriana Ribé; Javier Azua-Romeo; Ramon M Pujol; Francisco X Real
Journal:  J Invest Dermatol       Date:  2007-01-25       Impact factor: 8.551

6.  Lethal genes surviving by mosaicism: a possible explanation for sporadic birth defects involving the skin.

Authors:  R Happle
Journal:  J Am Acad Dermatol       Date:  1987-04       Impact factor: 11.527

Review 7.  Squamous cell carcinoma arising in a verrucous epidermal nevus.

Authors:  T Ichikawa; M Saiki; M Kaneko; T Saida
Journal:  Dermatology       Date:  1996       Impact factor: 5.366

Review 8.  Mosaicism in human skin. Understanding the patterns and mechanisms.

Authors:  R Happle
Journal:  Arch Dermatol       Date:  1993-11

9.  Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.

Authors:  Valentine J Hyland; Stephen P Robertson; Simon Flanagan; Ravi Savarirayan; Tony Roscioli; John Masel; Mark Hayes; Ian A Glass
Journal:  Am J Med Genet A       Date:  2003-07-15       Impact factor: 2.802

10.  Epidermal naevus syndrome (Solomon's syndrome) associated with bladder cancer in a 20-year-old female.

Authors:  Angel García de Jalón; Javier Azúa-Romeo; Miguel Angel Trivez; Daniel Pascual; Miguel Blas; Luis Angel Rioja
Journal:  Scand J Urol Nephrol       Date:  2004
View more
  7 in total

Review 1.  [Genetic basis of seborrheic keratosis and epidermal nevi].

Authors:  C Hafner; H Hafner; L Groesser
Journal:  Pathologe       Date:  2014-09       Impact factor: 1.011

Review 2.  Mosaic RASopathies.

Authors:  Christian Hafner; Leopold Groesser
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

3.  Analysis of mutations in the PIK3CA and FGFR3 genes in verrucous epidermal nevus.

Authors:  Ludmilla Queirós Miranda; Tainá Scalfoni Fracaroli; João Carlos Macedo Fonseca; Elisa Fontenelle; Raphael Pedro Machado Curvo; Luís Cristóvão Porto; Roberto Souto
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

4.  Keratinocytic epidermal nevus syndrome with Schwann cell proliferation, lipomatous tumour and mosaic KRAS mutation.

Authors:  Said Farschtschi; Victor-Felix Mautner; Silke Hollants; Christian Hagel; Marijke Spaepen; Christoph Schulte; Eric Legius; Hilde Brems
Journal:  BMC Med Genet       Date:  2015-02-10       Impact factor: 2.103

Review 5.  Pigmentary mosaicism: a review of original literature and recommendations for future handling.

Authors:  Anna Boye Kromann; Lilian Bomme Ousager; Inas Kamal Mohammad Ali; Nurcan Aydemir; Anette Bygum
Journal:  Orphanet J Rare Dis       Date:  2018-03-05       Impact factor: 4.123

6.  Transcriptomic Analysis of Human Keratinocytes Treated with Galactomyces Ferment Filtrate, a Beneficial Cosmetic Ingredient.

Authors:  Akiko Nakajima; Nahoko Sakae; Xianghong Yan; Tomohiro Hakozaki; Wenzhu Zhao; Timothy Laughlin; Masutaka Furue
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

7.  Late onset epidermal nevus with hypertrichosis and facial hemihypertrophy.

Authors:  M Saritha; Laxmisha Chandrashekar; Devinder Mohan Thappa; A Ramesh; Debdatta Basu
Journal:  Indian J Dermatol       Date:  2014-03       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.